Brians new company is doing great. I pray for him every day.
-
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Proove Bioscience
- Thread starter Anonymous
- Start date
-
- Tags
- None
Look guys. i dont work here nor did i ever
Im a lonely unemployed troll in a trailer in Texas.
Im a lonely unemployed troll in a trailer in Texas.
For goodness sakes!
LOOK AT THE VERY FIRST POST FROM PROOVE IN CAFEPHARMA!
The first post was in 2013 !!!!!
Almost 5 years ago!!!!
Former employees were already iffy about this place BACK THEN!! Seriously Brian?! What do you think was going to happen if you were already F-ing up in the VERY beginning. You had Time Meshkin, time to correct you mistakes but no, you decided to take a different path.
All the posts from the past 5 years were obviously, evidently a HUGE sign of what was yet to happen. All complaints complaints complaints complaints and endless complaints about Proove and you Brian. You are such an Idiot.
Do you think people hate you just because they want to??????
Ummm NO!
Omg seriously. Stop protecting him ppl
LOOK AT THE VERY FIRST POST FROM PROOVE IN CAFEPHARMA!
The first post was in 2013 !!!!!
Almost 5 years ago!!!!
Former employees were already iffy about this place BACK THEN!! Seriously Brian?! What do you think was going to happen if you were already F-ing up in the VERY beginning. You had Time Meshkin, time to correct you mistakes but no, you decided to take a different path.
All the posts from the past 5 years were obviously, evidently a HUGE sign of what was yet to happen. All complaints complaints complaints complaints and endless complaints about Proove and you Brian. You are such an Idiot.
Do you think people hate you just because they want to??????
Ummm NO!
Omg seriously. Stop protecting him ppl
did big boy many get questioned??
I heard he did Brian's dirty work. He knew what was going on. That's why he left quickly. Bm even told Lisa B to leave because this place was standing on thin ice
I heard he did Brian's dirty work. He knew what was going on. That's why he left quickly. Bm even told Lisa B to leave because this place was standing on thin ice
http://www.salem-news.com/articles/december082017/webster-deaths-dea-msp.php
Yet again, Part of BM crooked team
Yet again, Part of BM crooked team
This is so embarrassing for the people who gave him another fake award, 3 months later he was raided by the FBI and still under investigation. What a scam.
What is our deal? Ummmm = Justice
Proove was a scam Robert. Stop protecting him. Do you really think the Feds came to say Hi Brian, We came to visit you. Just a friendly visit
Umm no Robert. And I'll remind you that it is illegal to sign for the doctor
Guys check this out. This is on a whistleblower website. Proove case still pending..
United States ex. rel. Gardner v. Proove Biosciences, Inc., No. 2:15-cv-9158 (C.D. Cal.)
Complaint Filed: November 25, 2015
Complaint Unsealed: May 10, 2017
Intervention Status: The United States intervened on May 9, 2017.
Claims: The complaint alleges violations of the FCA and the federal Anti-Kickback Statute, 42 U.S.C. 1320-7b ("AKS"), for false claims submitted to Medicare. The relator asserts that the defendants billed for medically unnecessary genetic tests and engaged in a sophisticated kickback scheme with physicians.
Name of Relator: Bruce Gardner
Defendant's Business: Defendant Proove Biosciences, Inc. ("Proove") sells a number of genetic tests that help physicians determine whether a patient is at risk of addiction to opioid painkillers. Proove's most popular genetic tests are the Drug Metabolism Test and Opioid Risk Test. These two tests make up a significant portion of Proove's billings to Medicare and Medicaid. Relator's Relationship to Defendant: Bruce Gardner is the Vice President of Strategic Operations.
Relator's Counsel: Aaron J. Kemp and Ronald W. Chapman II of Chapman Law Group
Summary of Case: The relator alleges that Proove engaged in fraudulent billing practices in connection with a series of genetic tests designed to determine patients' susceptibility to opioid addiction based on their genetic profiles. The testing method developed by Proove is an alternative to a conventional genetic testing methodology that is understood to be accurate in 50% of patients. Proove claimed that studies showed that its tests could accurately predict opioid sensitivity in 93% of cases. The relator contends that the 93% figure is untrue and is based on a misrepresentation of the results of certain clinical tests. According to the relator, Proove's CEO and CFO were both aware of that misrepresentation. In fact, the relator claims, the Proove test only evaluated 2% of the genes known to affect susceptibility to opioid addiction. He further asserts that the estimate of the Proove test's reliability rests on a faulty algorithm, developed by a physician retained by Proove, which was manipulated to yield efficacy results that would warrant government approval of use of the testing on Medicare and Medicaid patients. The relator charges that the doctor who devised the algorithm continues to collect payments for every test sold, purportedly as a kickback for his role in gaining government approval.
The complaint alleges that Proove's genetic tests are unsupported by medical evidence, and the defendant billed Medicare and Medicaid for medically unnecessary tests using billing codes that were inapplicable to the genetic tests it was actually performing but which generated higher reimbursements.
In addition, the complaint asserts that the defendant improperly induced physicians to sign a Professional Services Agreement to sell and administer Proove's tests to patients in exchange for a fee from Proove and reimbursement from Medicare. The relator alleges that this complicated kickback scheme resulted in Medicare's payment of millions of dollars for unnecessary and expensive testing.
Current Status: Still Pending
Reasons to Watch: In addition to the alleged billing scheme, this case is notable because of its connection to the opioid crisis. Approximately 91 Americans die each day from opioid overdoses; recently there has been a nationwide effort to reduce the availability of opioidrelated painkillers. Many states are working in partnership to address opioid abuse. The allegations against Proove highlight the potential risk to the health care system of unscrupulous providers attempting to profit from this very serious public health threat.
United States ex. rel. Gardner v. Proove Biosciences, Inc., No. 2:15-cv-9158 (C.D. Cal.)
Complaint Filed: November 25, 2015
Complaint Unsealed: May 10, 2017
Intervention Status: The United States intervened on May 9, 2017.
Claims: The complaint alleges violations of the FCA and the federal Anti-Kickback Statute, 42 U.S.C. 1320-7b ("AKS"), for false claims submitted to Medicare. The relator asserts that the defendants billed for medically unnecessary genetic tests and engaged in a sophisticated kickback scheme with physicians.
Name of Relator: Bruce Gardner
Defendant's Business: Defendant Proove Biosciences, Inc. ("Proove") sells a number of genetic tests that help physicians determine whether a patient is at risk of addiction to opioid painkillers. Proove's most popular genetic tests are the Drug Metabolism Test and Opioid Risk Test. These two tests make up a significant portion of Proove's billings to Medicare and Medicaid. Relator's Relationship to Defendant: Bruce Gardner is the Vice President of Strategic Operations.
Relator's Counsel: Aaron J. Kemp and Ronald W. Chapman II of Chapman Law Group
Summary of Case: The relator alleges that Proove engaged in fraudulent billing practices in connection with a series of genetic tests designed to determine patients' susceptibility to opioid addiction based on their genetic profiles. The testing method developed by Proove is an alternative to a conventional genetic testing methodology that is understood to be accurate in 50% of patients. Proove claimed that studies showed that its tests could accurately predict opioid sensitivity in 93% of cases. The relator contends that the 93% figure is untrue and is based on a misrepresentation of the results of certain clinical tests. According to the relator, Proove's CEO and CFO were both aware of that misrepresentation. In fact, the relator claims, the Proove test only evaluated 2% of the genes known to affect susceptibility to opioid addiction. He further asserts that the estimate of the Proove test's reliability rests on a faulty algorithm, developed by a physician retained by Proove, which was manipulated to yield efficacy results that would warrant government approval of use of the testing on Medicare and Medicaid patients. The relator charges that the doctor who devised the algorithm continues to collect payments for every test sold, purportedly as a kickback for his role in gaining government approval.
The complaint alleges that Proove's genetic tests are unsupported by medical evidence, and the defendant billed Medicare and Medicaid for medically unnecessary tests using billing codes that were inapplicable to the genetic tests it was actually performing but which generated higher reimbursements.
In addition, the complaint asserts that the defendant improperly induced physicians to sign a Professional Services Agreement to sell and administer Proove's tests to patients in exchange for a fee from Proove and reimbursement from Medicare. The relator alleges that this complicated kickback scheme resulted in Medicare's payment of millions of dollars for unnecessary and expensive testing.
Current Status: Still Pending
Reasons to Watch: In addition to the alleged billing scheme, this case is notable because of its connection to the opioid crisis. Approximately 91 Americans die each day from opioid overdoses; recently there has been a nationwide effort to reduce the availability of opioidrelated painkillers. Many states are working in partnership to address opioid abuse. The allegations against Proove highlight the potential risk to the health care system of unscrupulous providers attempting to profit from this very serious public health threat.
You do know you are going to look like an imported idiot later when the findings and charges come out right?
But I'm sitting on Millions and you're broke and lonely. Who's the fool ?
What is our deal? Ummmm = Justice
Proove was a scam Robert. Stop protecting him. Do you really think the Feds came to say Hi Brian, We came to visit you. Just a friendly visit
Umm no Robert. And I'll remind you that it is illegal to sign for the doctor
Justice? hahah calm down Batman. Move on.
and this ain't Robert you buffoon.
What is our deal? Ummmm = Justice
Proove was a scam Robert. Stop protecting him. Do you really think the Feds came to say Hi Brian, We came to visit you. Just a friendly visit
Umm no Robert. And I'll remind you that it is illegal to sign for the doctor
Dude, you need serious help. Go look for a job instead of loafing all day.
I have a job dude. Brian's actions will not just disappear. Stop posting here
Great stuff, thanks for sharing. Private insurers should follow suit. Where did JM spend all his time? TX, SC, and Fl ? Somebody should alert the private payers in those states. A simple cut and paste would do.